Updated Jul 16, 2026 · Last SEC filing 2026-07-09
Vor Biopharma Inc. (VOR) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-09. 3 Form 8-K material event filings were reported by VOR in the last 90 days. InsiderAlpha tracks every VOR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Biological Products, (No Diagnostic Substances) (SIC 2836) |
|---|---|
| SEC CIK | 0001817229 |
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-07-09 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 165.2K | $15.77 | $2.60M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 172.0K | $15.77 | $2.71M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 458.4K | $16.28 | $7.46M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 53.6K | $16.01 | $859K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 153.7K | $15.97 | $2.46M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 530.6K | $16.15 | $8.57M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 828 | $15.75 | $13K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 135.2K | $16.59 | $2.24M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 130.9K | $16.91 | $2.21M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 353.2K | $16.32 | $5.76M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 6.8K | $18.50 | $125K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 44.7K | $17.31 | $774K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 537.8K | $16.51 | $8.88M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 258.5K | $18.23 | $4.71M | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | S — Open-market sale | 1.5K | $19.06 | $29K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Vor Biopharma Inc. (VOR). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 4 | $12.78M |
| ZACCARDELLI DAVID | 1 | — |
| Beckman Daniella | 1 | — |
| Namouni Fouad | 1 | — |
| Cumbo Alexander | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in VOR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live VOR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.